PNC-27 Australia | Anti-Cancer Research Peptide
PNC-27 is a synthetic peptide widely referenced in scientific literature examining the p53–HDM-2 interaction and selective cancer-cell membrane activity. As one of the most studied anti-cancer research peptides available in Australia, PNC-27 is cited across investigations into tumour-cell targeting, membranolysis, and apoptotic signalling pathways.
PNC-27 is supplied in a 10mg strength as a lyophilised powder with third-party verification.
What Is PNC-27?
PNC-27 is a synthetic peptide containing an HDM-2 binding domain linked to a transmembrane-penetrating sequence. In published literature it is frequently referenced as a subject of investigation into its reported ability to bind HDM-2 at the surface of cancer cells and induce membrane disruption, while sparing non-cancerous cells in the models studied. Its selective mechanism makes it a common comparator in academic and preclinical research exploring targeted anti-cancer peptides.
PNC-27 Specifications
Peptide: PNC-27
Strength: 10mg
Form: Lyophilised powder
Purity: 99%+
Verification: COA provided & independently tested
Storage: Store at 2–8°C
Quality & Testing
Every batch supplied by Pureform Labs is independently analysed by a third-party laboratory for identity and purity. A Certificate of Analysis (COA) is available for each product so researchers can verify what they receive. View current lab results on our Lab Results page.
Ordering PNC-27 in Australia
PNC-27 is held in local Australian stock and dispatched same day on orders placed before cut-off, with tracked delivery nationwide. On arrival, store the lyophilised powder refrigerated at 2–8°C, away from light, to maintain stability.
Disclaimer: This product is intended strictly for laboratory research use only. It is not for human or animal consumption, and not for diagnostic or therapeutic use.
